Searched for
METOPROLOL SUCCINATE
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...- Granules India recalls 33,000 bottles of blood lowering medication in USGranules India is recalling over 33,000 bottles of Metoprolol Succinate, a generic blood pressure medication, in the US due to manufacturin...
- Regulator bans 35 combination drugs over safety issuesIndia's drug regulator has banned the manufacture and sale of 35 fixed dose combinations (FDCs), citing concerns over patient safety and po...
- These healthcare and pharma stocks may deliver more than 20% in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...
- Finally out of the woods? 4 small and midcap pharma stocks with an upside potential of up to 26%Pharma as a sector has been under pressure for a very long time. Some time USFDA issues, at other instances of pricing pressure in US marke...
- Nifty healthcare index stocks analysts suggest buying have potential upside of more than 19%Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...
- Cipla gets USFDA nod for hypertension, cardiac drugCipla said, Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure, Angina ...
- need2know: 12 market-moving macro triggers to watch todayA lowdown on the top macro triggers that may move market on Tuesday.
- Cadila Healthcare soars over 4% post USFDA drug nodCLSA has upgraded Cadila Healthcare to ‘buy’ from ‘underperform’.
- Zydus Cadila gets USFDA nod for cardiac drugThe product will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad, Zydus Cadila said in a statement.
- Wockhardt recalls over 50 lakh bottles of various drugs in USAs per the information available on the USFDA, Wockhardt is recalling the drugs for current good manufacturing practice (CGMP) deviations.
- Dr Reddy's Laboratories to expand capacity of manufacturing units in TelanganaDr Reddy's Laboratories is set to expand the capacity of three of its bulk drugs and intermediates manufacturing plants located in Telangan...
- Wockhardt, Cadila and Hospira voluntarily recall drugs in USDrug firms Wockhardt, Cadila Healthcare and Hospira are voluntarily recalling certain lots of drugs in US, according to the US Food and Dru...
- Dr Reddy's recalls over 13,000 bottles of hypertension drug: FDADr Reddy's Laboratories Ltd is recalling 13,560 bottles of the high blood pressure drug metoprolol succinate in US after it failed a dissol...
- Ten stocks in focus in Friday morning tradeIndian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.
- Wockhardt recalls 8,712 bottles of hypertension drug in US marketWockhardt is recalling over 8,000 bottles of anti-hypertension drug Metoprolol Succinate extended-release tablets following failure of a di...
- Wockhardt recalls over 109,000 bottles of hypertension drug in USWockhardt Ltd is recalling 109,744 bottles of a high blood pressure drug in the US after it failed a dissolution test, the US Food and Drug...
- Six stocks to be in focus on Wednesday morning tradeThe Sensex gained momentum on Wednesday after a positive start. Here are the stocks that are likely to be in action in trade today.
- Dr Reddy's launches high blood pressure tablets in US marketDr Reddy's Laboratories today said it has launched Metoprolol Succinate tablets used for treating high blood pressure in the American marke...
- Wockhardt gets US FDA approval for generic version of ToprolXLPharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for...
Load More
